e-learning
resources
Virtual 2020
Pre-Congress Content
What is hot in idiopathic pulmonary fibrosis?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Quantitative CT for the assessment of disease severity in interstitial lung disease
D. Parr (Coventry (West Midlands), United Kingdom), E. Helm (Coventry (West Midlands), United Kingdom), J. Shakespeare (Coventry (West Midlands), United Kingdom), R. Hughes (Coventry (West Midlands), United Kingdom), A. Bhalerao (Warwick, United Kingdom)
Source:
Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Session:
What is hot in idiopathic pulmonary fibrosis?
Session type:
E-poster session
Number:
1799
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Parr (Coventry (West Midlands), United Kingdom), E. Helm (Coventry (West Midlands), United Kingdom), J. Shakespeare (Coventry (West Midlands), United Kingdom), R. Hughes (Coventry (West Midlands), United Kingdom), A. Bhalerao (Warwick, United Kingdom). Quantitative CT for the assessment of disease severity in interstitial lung disease. 1799
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Quantitative assessment of lung pathology in interstitial lung diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 243s
Year: 2001
CT and interstitial lung disease
Source: International Congress 2018 – PG4 Imaging of the chest
Year: 2018
Predictive value of 18F-FDG PET/CT for chemotherapy-related acute exacerbation of interstitial lung disease in lung cancer patients with interstitial lung disease
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Quantitative analysis of pulmonary cysts and emphysema on computed tomography: Lymphangioleiomyomatosis, Birt-Hogg-Dubé syndrome and chronic obstructive lung disease
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Quantitative computed tomography imaging in asthma and chronic obstructive pulmonary disease.
Source: International Congress 2018 – Imaging biomarkers and quantitative imaging
Year: 2018
Ultra-low dose CT in the assessment of diffuse lung disease: Comparison with conventional images
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
Relationship between progression of disease on longitudinal high-resolution CT scans and progression of functional impairment in asbestosis
Source: Annual Congress 2007 - The air we breathe at home and at work
Year: 2007
Correlation of high resolution computed tomography (HRCT) findings with disease severity in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2007 - Imaging modalities in asthma, COPD and emphysema
Year: 2007
Assessment of disease severity using imaging scores in pulmonary sarcoidosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent
Source: Eur Respir J, 55 (4) 1901519; 10.1183/13993003.01519-2019
Year: 2020
Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease
Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021
Year: 2022
The Value of 18F-FDG PET/CT in evaluating disease severity in idiopathic pulmonary fibrosis
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Factors influencing the decline in lung density in a Danish lung cancer screening cohort
Source: Eur Respir J 2012; 40: 1142-1148
Year: 2012
Correlation of high resolution CT patterns to pulmonary function tests in patients with interstitial lung diseases
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Quantitative CT characterisation of stable COPD patients relates to COPD severity and exacerbation frequency
Source: Annual Congress 2006 - COPD: imaging and computer applications
Year: 2006
A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Volumetric CT analysis of normal lung as a predictor of mortality in idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016
Use of MRI for functional and structural assessment of interstitial lung disease
Source: International Congress 2018 – Emerging and novel imaging biomarkers in drug-induced interstitial lung disease
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept